S
SKBI

SignatureFD’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

SignatureFD’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-76
Closed – – 1448
2015
Q2 		$0 Buy
+76
New +$260 ﹤0.01% 1187

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SignatureFD's SKBI Position: Q3 2015 in Review

SignatureFD sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2015, closing a stake of 76 shares.

SignatureFD first reported a position in SKBI in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 10 funds tracked by Wall St. Rank hold SKBI as of Q3 2015.

  • SignatureFD reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2015 after selling out during the quarter.
  • SignatureFD sold 76 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2015.
  • SignatureFD first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q2 2015 and held it in 1 quarter.
  • SignatureFD's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $0 in Q2 2015.
  • 10 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2015.

Based on SignatureFD's 13F filing for Q3 2015, filed 23 Oct 2015.